ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

ASCO Street Team

ASCO Street Team Coverage

As part of our Street Team coverage of the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting we present video interviews and Q&As with experts in the field who discuss various issues impacting the world of oncology.

ASCO Street Team

In this peer-to-peer discussion two experts discuss the nuances and challenges of treating elderly patients with myeloma, and why therapies need to be tailored based on frailty status rather than age.

This video highlights results of the SUNSHINE study, which found that high-dose vitamin D added to standard treatment slowed disease progression in newly diagnosed metastatic colorectal cancer.

This video highlights the latest studies presented at the 2017 ASCO Annual Meeting on the treatment of HER2-positive breast cancer.

This video examines how a change to weight-based pembrolizumab dosing in first-line PD-L1–positive lung cancer could save nearly $1 billion in US healthcare costs.

This video examines challenges and opportunities in getting older patients with cancer enrolled in clinical trials.

This video examines clinical and genomics data from the NCI 9012 trial, which studied abiraterone combined with a PARP inhibitor in patients with metastatic castration-resistant prostate cancer.

This video reviews results of LUX-Head & Neck 2, a randomized phase III trial that studied afatinib as adjuvant therapy in patients with unresected squamous cell head and neck cancer.

Pages

Subscribe to ASCO Street Team on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.